QuartrQuartr

NBIX: Ingrezza and Crinecerfont drive growth amid industry challenges, with strong market expansion ahead

Waktu baca kurang dari 1 menit

Strong execution led to significant growth for Ingrezza and a successful Crinecerfont launch, with both products showing substantial market potential. Strategic focus remains on maximizing current assets, managing IRA impacts, and leveraging a growing sales force, while upcoming R&D efforts aim to drive future innovation.

Based on Neurocrine Biosciences, Inc. [NBIX] Piper Sandler 37th Annual Healthcare Conference Audio Transcript — Dec. 2 2025

Pernyataan Penyangkalan